Clinical outcomes
Labs, imaging, provider visits, diagnoses — structured and unified across every patient.
The story of a medicine begins after the trial ends.
Traditional real-world evidence is assembled after the fact — scraped from claims and records. StoryMD generates it natively: a continuous, consented, AI-powered record captured as patients move through their health journeys — from the moment a therapy reaches them and for years beyond.
Medicine has always needed three kinds of evidence. Until now, it only had two.
Clinical trials prove a therapy can work under ideal conditions. Traditional real-world evidence — claims, EHRs, retrospective surveys — shows what happened after approval, assembled after the fact. Neither was built to answer the question that matters most for a drug's long-term success: how, why, and for whom does it actually work in real life? StoryMD's native real-world evidence is the third generation — collected directly from patients, prospectively, in real time.
Clinical trials
Can it work?
Highest scientific rigor, controlled design, regulatory gold standard. Limited population, duration, and visibility into daily life.
Traditional RWE
What happened?
Large, longitudinal, lower cost. But retrospective, incomplete, and not built for research — so it rarely explains why.
StoryMD's Native RWE
How, why, and for whom?
Prospective, structured, first-party, continuous. The complete patient journey, as it happens.
A living digital portrait of every patient, every day.
StoryMD captures the full human context of disease — the factors that govern real drug performance but never appear in a trial case report form.
Medication adherence
Exact dosing patterns, missed doses, switches — the real story of how patients take their therapy.
Symptom progression
Patient-reported symptoms tracked over months and years — the longitudinal arc no trial captures.
Wearable biometrics
Continuous heart rate, sleep quality, activity levels, HRV, and glucose data from integrated devices.
Lifestyle & behavior
Diet, exercise, stress, alcohol, smoking, and environment — the daily variables that drive real-world performance.
Demographics & genetics
Age, ethnicity, comorbidities, and genetic factors that influence response across populations.
Treatment context
Concurrent medications, dosing adjustments, and prior therapies — the full therapeutic picture.
Patient & caregiver narrative
Patient journals and caregiver observations — the qualitative texture and outside perspective on living with disease.
AI-derived signals
Pattern detection across all streams — surfacing what no individual data point can reveal alone.
Together, these nine data streams create a longitudinal patient record that has never existed anywhere in medicine — continuously growing, never closed, and impossible to build without the trust of the patient community at its center.
Every party gets what they could never build alone.
Foundations gain digital leadership. Pharma earns continuous real-world evidence. Patients receive a free, world-class platform. And researchers gain a new source of longitudinal evidence.
For foundations
Digital leadership in your disease area
Deploy a white-labeled platform branded for your foundation, governed by you, and funded by your pharma partner. Become the natural digital home for your community.
For pharma
Continuous real-world evidence
Adherence patterns, side-effect signals, lifestyle interactions, and competitive landscape data — continuously, from the patients living with your therapies every day.
For patients
A free world-class health platform
Track symptoms, medications, labs, wearables, and daily life through an AI-guided health journal — sponsored, secure, and always yours.
For researchers
A new source of longitudinal evidence
Patient-centered, prospective data that complements clinical trial and claims-based research, with publication-ready datasets and co-authorship opportunities through foundation partners.
What becomes visible when patients tell the full story.
The dataset is the foundation. AI is the engine that transforms it into insight — surfacing patterns in real patient lives that no controlled study can reveal.
Adherence
Understanding treatment adherence
Identify when and why patients reduce or stop therapy in real life. Map adherence patterns to behavioral, lifestyle, and socioeconomic factors. Distinguish intentional discontinuation from adverse-event-driven dropout.
Safety
Real-world side effect signals
Detect adverse signals weeks before they surface in formal reporting systems. Cross-reference against age, genetics, ethnicity, and comorbidities. Identify subpopulations with different tolerability profiles.
Lifestyle
Lifestyle & treatment interactions
Uncover how diet, sleep quality, and exercise affect treatment outcomes. Identify environmental factors that influence results. Capture context invisible in every prior study.
Outcomes
Longitudinal outcome intelligence
Track how quality of life, symptoms, and function evolve over years. Understand how treatment sequencing affects long-term outcomes. Identify which patient profiles respond best to which approaches.
Your health story, finally in one place.
Patients are not data sources. They are the reason this platform exists — and the most important contributor to everything it discovers. StoryMD is built around their experience.
A unified record of your health journey
Labs, imaging, symptoms, medications, and daily experiences — all in one place, organized over time. The first complete picture of your disease as you actually live it.
AI-guided insights as your data grows
The platform learns alongside you — connecting patterns in your labs, symptoms, and lifestyle that your care team may never see in a 20-minute appointment.
Learn from others on the same path
Aggregated, de-identified insights from patients like you — what others have experienced, how they've navigated treatment, and what has helped — without compromising anyone's privacy.
You own your data. Always.
Patients decide what they share, with whom, and for how long — with granular consent controls at every step. Your data advances science only when you choose for it to.
Patient-consented HIPAA compliant GDPR frameworks Full data ownership Free access
Real-world evidence, native by design.
Whether you're a pharma partner, a disease foundation, or a patient advocate — the window to shape this category is open now.
- 01
Schedule a discovery call
Meet the StoryMD team and explore fit for your disease community or drug indication.
- 02
See the platform in action
Live demo of the AI health journal, data infrastructure, and intelligence layer.
- 03
Co-design your pilot
Work with our team to shape the program — we handle the infrastructure, you bring the community and the direction.